RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 34-44
  • Commentary: Why residents want to 'draft Duffy' for City Council

    With no offense to Diane Dixon versus Michael Glenn, or Michael Toerge versus Scott Peotter, or even Tim Brown versus Roy Englebrecht, we may soon have a Newport Beach City Council race to watch. On Wednesday, the "Draft Duffy" movement will start with a...
  • Ackman warns Allergan on offer

    Activist investor Bill Ackman warned Botox maker Allergan Inc. on Monday that it would be unwise to court potential acquirers as an alternative to the offer that he and Valeant Pharmaceuticals International Inc. have made for the company. Last month,...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • Shire to acquire San Diego-based Lumena in more than $260 million deal

    Drug maker Shire is buying San Diego-based Lumena Pharmaceuticals for more than $260 million, a deal that expands the company's pipeline of rare disease treatments. The Irish company, producer of Adderall XR, plans to make a cash payment at the sale's...
  • Allergan rejects Valeant's takeover bid, but it's probably not over

    Botox maker Allergan Inc. rejected a $46-billion takeover offer from a Canadian rival, setting the stage for what analysts said may become a long and nasty fight for control of the Irvine company and its prized collection of eye and skin medications....
  • Valeant to increase bid for Allergan

    Valeant to increase bid for Allergan
    The stakes for Botox maker Allergan Inc. just got higher. Valeant Pharmaceutical International Inc. said it intends to raise its bid for Allergan, one day after the Irvine company defiantly rejected its initial offer as too low. In a letter to...
  • Ackman wants shareholders to push Allergan into takeover talks

    Activist investor Bill Ackman wants Allergan Inc. shareholders to vote on a resolution that would encourage the Botox maker to meet with its potential acquirer, Valeant Pharmaceuticals International Inc. In a filing Tuesday with the Securities and...
  • Valeant Pharmaceuticals vows to boost its $46-billion bid for Allergan

    The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month. Meanwhile, the Canadian firm's partner in the offer, activist...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Allergan urges shareholders to reject Valeant offer

    Allergan urges shareholders to reject Valeant offer
    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...